Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Intensive Care Med. 2019 Sep 23;46(1):107–109. doi: 10.1007/s00134-019-05781-0

Financial Stress after Critical Illness: an Unintended Consequence of High-Intensity Care

Nita Khandelwal 1,2, Peter May 3,4, J Randall Curtis 2,5
PMCID: PMC7035881  NIHMSID: NIHMS1540490  PMID: 31549224

For patients with chronic, life-limiting illness, deterioration in health can result in admission to the ICU, with the goal of restoration of health back to or near their prior quality of life. However, such patients may also receive costly, high intensity care that they find burdensome and inconsistent with their values and goals.1 Further, this high intensity care may be ineffective,2 and place unnecessary psychological and physical burden on patients and their family.3 For patients who survive, they may be at risk for experiencing an outcome that they consider to be worse than death, such as permanently needing help with activities of daily living like toileting or bathing.4 These unfortunate realities raise the question of whether there is an important opportunity to apply the principle of “less is more” in the care of some patients with chronic, life-limiting illness.

As intensivists, we aim to provide goal-concordant care by informing patients and family members of expected outcomes, as well as potentially adverse effects of high intensity treatments, with the hope of helping patients and family members decide whether or not the care we offer and the achievable outcomes are consistent with patients’ values, goals and preferences. We also continue to seek new interventions that may improve the physical, cognitive and psychological outcomes for critically ill patients and their family members. Yet, there is a potentially harmful adverse effect of high intensity care that never makes it to the goals-of-care discussions or family conference –that is, the financial burden that critically ill patients and their family members can experience.

Current research and the dialogue on financial “toxicity”, a term used to describe the harmful financial side effects of treatment,5 remain limited primarily to patients with cancer in the U.S. However, even in settings with universal health coverage, patients with serious illness are not protected against financial hardship.6 Key components of financial toxicity include both objective financial burden (e.g. out-of-pocket costs, lost income, unemployment) and subjective financial distress (e.g. perceived future financial prospects).7 Among patients with cancer, the outcomes of increased financial distress and decreased health-related quality of life are strongly correlated, indicating that financial toxicity is a clinically-relevant patient-centered outcome.8 In this population, financial toxicity has been associated with decreased treatment adherence9 and quality of life,10 as well as increased symptoms10,11 and even mortality12—all outcomes that are of great importance to critically ill patients and their family members.

Although there are fewer studies in the context of critical illness, the prevalence of finance-related stress is also high among patients requiring intensive care and their families and this stress is a mediator of symptoms of anxiety and depression.13 There is a complex relationship at play between critical illness, the need for high intensity care, family and patient financial stress, and important patient- and family-centered outcomes (Figure 1). This relationship is magnified for patients who are admitted to the ICU with an underlying chronic, life-limiting illness who are at particularly high risk of death or at high risk of needing continued high-intensity care after ICU discharge for an outcome that they may consider to be less than desirable.

Figure 1:

Figure 1:

Conceptual model demonstrating the complex relationship between critical illness, the need for high intensity care, family and patient financial stress, and important patient- and family-centered outcomes.

In the U.S., out-of-pocket spending on health care is increasing for patients, through higher deductibles and increases in copayments. With the lack of an out-of-pocket maximum and a relatively high co-payment for hospitalizations, traditional Medicare fee-for-service alone does not insulate individuals from the financial burden of high intensity care and repeated hospitalizations.14 Although the high burden of out-of-pocket costs is less of an issue in many other countries, these costs are only one of the many contributors to financial stress. In a multicenter longitudinal study, nearly one-half of previously employed survivors of acute respiratory distress syndrome (ARDS) were jobless 12 months later, and over the 12-month follow-up, 70% suffered lost earnings averaging 60% of pre-ARDS annual earnings.15

Family member caregivers of ICU survivors also experience financial burden that impacts their quality of life and psychological well-being.13,16 Although out-of-pocket costs have less of an impact in countries with universal healthcare coverage, the post-discharge costs (e.g. home care, equipment, time away from work for medical appointments), loss of wages, and changes in employment resulting from family caregiving for seriously ill loved ones is substantial. In a study conducted in the UK in patients with advanced disease, informal care increased the total healthcare cost by >250%.17

Seriously-ill patients report that one of their top concerns is having healthcare costs covered to avoid placing a financial burden on loved ones.18,19 Therefore, we must acknowledge this important goal and source of stress that permeates many aspects of our patients’ and their family members’ lives and directly impacts many of the outcomes we seek to improve, such as quality of life and psychological distress. Further, although there is evidence that financial stress affects quality of life, the opposite causal pathway is also possible. Conceptually, lower quality of life could decrease earning power and capacity to provide care to family members. This is an important area for future research.

Critics may argue that even if financial stress is prevalent, it is not easily modifiable by clinicians and others who work in the healthcare setting. That may be true to some extent for out-of-pocket costs and aspects of the objective burden; however, prior research has demonstrated that the presence of social support significantly improves quality of life and decreases the extent to which financial concerns are important stressors for patients, suggesting that interventions targeted at improving support systems for critically ill patients and their family members in and after an ICU stay may provide benefit.13 Additionally, reducing the perception of financial stress that originates from uncertainty and the lack of information about the types of costs to expect during and after a hospitalization and what to prepare for, may be modifiable with better access to financial counselors and post-discharge financial navigators.20

For patients with chronic and life-limiting illnesses, admission to the ICU near the end of life or specific high-intensity treatments in the ICU may not be consistent with patients’ values, goals and preferences and may be non-beneficial. In this context, advance care planning and palliative care interventions are designed to clarify values, goals and preferences and ensure that the medical care delivered is goal-concordant. We should also consider how these and other interventions can acknowledge and address financial stress and help mitigate the impact it has on the lives of patients and their family members. If avoiding unwanted or non-beneficial care can help reduce this stress, this may be another context where “less is more”.

Footnotes

Publisher's Disclaimer: This Author Accepted Manuscript is a PDF file of an unedited peer-reviewed manuscript that has been accepted for publication but has not been copyedited or corrected. The official version of record that is published in the journal is kept up to date and so may therefore differ from this version.

References

  • 1.Lynn J, Teno JM, Phillips RS, et al. Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 1997;126:97–106. [DOI] [PubMed] [Google Scholar]
  • 2.Teno JM, Gozalo P, Khandelwal N, et al. Association of Increasing Use of Mechanical Ventilation Among Nursing Home Residents With Advanced Dementia and Intensive Care Unit Beds. JAMA internal medicine 2016;176:1809–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28:4457–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rubin EB, Buehler AE, Halpern SD. States Worse Than Death Among Hospitalized Patients With Serious Illnesses. JAMA internal medicine 2016;176:1557–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zafar SY. Financial Toxicity of Cancer Care: It’s Time to Intervene. Journal of the National Cancer Institute 2016; 108. [DOI] [PubMed] [Google Scholar]
  • 6.Bhoo-Pathy N, Ng CW, Lim GC, et al. Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action. Journal of oncology practice / American Society of Clinical Oncology 2019:JOP1800619. [DOI] [PubMed] [Google Scholar]
  • 7.Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park, NY) 2013;27:80–1, 149. [PMC free article] [PubMed] [Google Scholar]
  • 8.de Souza JA, Yap BJ, Wroblewski K, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the Comprehensive Score for financial Toxicity (COST). Cancer-Am Cancer Soc 2017;123:476–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Winn AN, Keating NL, Dusetzina SB. Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016;34:4323–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer. Journal of Clinical Oncology 2016;34:1732-+. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chan RJ, Gordon LG, Tan CJ, et al. Relationships Between Financial Toxicity and Symptom Burden in Cancer Survivors: A Systematic Review. Journal of pain and symptom management 2019;57:646–60 el. [DOI] [PubMed] [Google Scholar]
  • 12. Ramsey SD, Bansal A, Fedorenko CR, et al. Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer. Journal of Clinical Oncology 2016;34:980-+. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Khandelwal N, Hough CL, Downey L, et al. Prevalence, Risk Factors, and Outcomes of Financial Stress in Survivors of Critical Illness. Critical care medicine 2018;46:e530–e9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Khandelwal N, White L, Curtis JR, Coe NB. Health Insurance and Out-of-Pocket Costs in the Last Year of Life Among Decedents Utilizing the ICU. Critical care medicine 2019;47:749–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kamdar BB, Huang M, Dinglas VD, et al. Joblessness and Lost Earnings after Acute Respiratory Distress Syndrome in a 1-Year National Multicenter Study. American journal of respiratory and critical care medicine 2017;196:1012–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.van Beusekom I, Bakhshi-Raiez F, de Keizer NF, Dongelmans DA, van der Schaaf M. Reported burden on informal caregivers of ICU survivors: a literature review. Crit Care 2016;20:16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dzingina MD, Reilly CC, Bausewein C, et al. Variations in the cost of formal and informal health care for patients with advanced chronic disease and refractory breathlessness: A cross-sectional secondary analysis. Palliative medicine 2017;31:369–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Downey L, Engelberg RA, Curtis JR, Lafferty WE, Patrick DL. Shared priorities for the end-of-life period. Journal of pain and symptom management 2009;37:175–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA : the journal of the American Medical Association 2000;284:2476–82. [DOI] [PubMed] [Google Scholar]
  • 20.Shankaran V, Leahy T, Steelquist J, et al. Pilot Feasibility Study of an Oncology Financial Navigation Program. Journal of oncology practice / American Society of Clinical Oncology 2018;14:el22–e9. [DOI] [PubMed] [Google Scholar]

RESOURCES